Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Amprion Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. The busiest examiner for the company is FONTAINHAS, AURORA M, who is responsible for the only active matter. This examiner handles the company's entire current pending workload.
With only 1 pending office action, the company's current prosecution is very concentrated. The use of 1 distinct art unit and 1 distinct examiner indicates that the biotechnology and pharmaceutical claims are being reviewed by a single specialized individual. FONTAINHAS, AURORA M is the sole examiner currently providing feedback on the company's pending application. This focus in a single art unit ensures that the company's 1 pending office action is evaluated by a specialist in the biotechnology field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FONTAINHAS, AURORA M | 1 | 37.9% | +49.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426786 | DETECTION OF MISFOLDED ALPHA SYNUCLEIN PROTEIN | FONTAINHAS, AURORA M | 53d |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18426786 | DETECTION OF MISFOLDED ALPHA SYNUCLEIN PROTEIN | FONTAINHAS, AURORA M | 1675 | §103Other | Non-Final OA | 53d | Pending | Jan 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial